Hrsa Hiv Pregncy

download Hrsa Hiv Pregncy

of 30

Transcript of Hrsa Hiv Pregncy

  • 8/7/2019 Hrsa Hiv Pregncy

    1/30

    1

    Jean R. Anderson, MD

    DirectorJohns Hopkins HIV Womens Health Program

    Care of Women with HIV Living in

    Limited-Resource Settings

    HIV and Pregnancy

  • 8/7/2019 Hrsa Hiv Pregncy

    2/30

    2

    Objectives

    Review significance of HIV during pregnancy and

    magnitude of the problem

    Review HIV-related issues to be considered prior to

    pregnancy

    Discuss effects of pregnancy on HIV infection and

    effects of HIV infection on pregnancy course and

    outcome

    Discuss mother-to-child transmission (MTCT) and itsprevention

    Discuss care of pregnant woman with HIV

  • 8/7/2019 Hrsa Hiv Pregncy

    3/30

    3

    HIV and Pregnancy Why Is It

    Important?

    HIV may have adverse effect on pregnancy course or

    outcome

    More than 90% of pediatric HIV/AIDS cases are caused

    by MTCT

    Most children born to HIV-positive mothers in limited-

    resource settings will be orphaned when one or both

    parents die

    Women without HIV may place themselves at risk forinfection while trying to get pregnant

    Majority of women with HIV are of childbearing age

  • 8/7/2019 Hrsa Hiv Pregncy

    4/30

    4

    Prevalence of HIV (Type-1) among

    Pregnant Women

    0% 10% 20% 30% 40% 50%

    Nigeria

    Uganda

    Kenya

    South Africa

    Malawi

    Rwanda

    Botswana

    ThailandCambodia

    Brazil

    Honduras

    Haiti

    % Positive

    Source: DeCock et al 2000.

    Latin

    America

    Asia

    Africa

  • 8/7/2019 Hrsa Hiv Pregncy

    5/30

    5

    0

    10

    20

    30

    40

    50

    60

    70

    Carletonville,SouthAfrica

    ,

    1998(urban)

    Mutasadistrict,Zimbabwe

    ,

    1998(rural)

    Kisumu,Kenya,1997(urb

    an)

    Lusaka,Zam

    bia,1995(urba

    n)

    Mposhi,Zambia,1996(rur

    al)

    Ndola,Zam

    bia1997(urba

    n)

    Kisesa,Tanzania,1997(ru

    ral)

    Yaounde,Cam

    eroon1997(urb

    an)

    Cotonou,Benin1997(urba

    n)

    FortPortal,Uganda1995(urb

    an)

    Masaka,Uganda1996(rur

    al)

    Women, 15-19

    Women, 20-24

    HIVprevalence(%

    )

    HIV Prevalence among Women Age 1524Various African Studies, 19951998

    Source: UNAIDS June 2000.

  • 8/7/2019 Hrsa Hiv Pregncy

    6/30

    6

    Effect of HIV on Fertility

    Prior STIs or pelvic inflammatory disease

    Direct effects of HIV

    Decreased fertility seen after adjustment for age, lactation,

    illness, STIs

    Worsened fertility in women with symptomatic HIV or co-

    infected with syphilis

    Pregnancy loss more common with HIV infection

    Decreased sexual activity with advanced HIV

    Source: Lancet 1998.

  • 8/7/2019 Hrsa Hiv Pregncy

    7/30

    7

    Voluntary Counseling and Testing

    (VCT) in Women of Childbearing Age

    Information about HIV and pregnancy

    Risk assessment

    Prevention of HIV transmission or acquisition

    Prevention of unintended pregnancy

    Dual protection with condoms

    Need to involve men in VCT!

  • 8/7/2019 Hrsa Hiv Pregncy

    8/30

    8

    Goals of VCT in Antenatal Care

    Educate about HIV

    Reduce stigma

    Prevent new HIV infections in pregnancy

    Identify women with HIV

    Stabilize and maintain maternal health

    Prevent HIV transmission to uninfected sexual or drug

    using partners

    Reduce risk of MTCT Plan for future

  • 8/7/2019 Hrsa Hiv Pregncy

    9/30

    9

    Special Counseling Issues for HIV-Positive Women

    Who Are Pregnant or Considering Pregnancy

    Effect of HIV on fertility

    Effect of HIV on pregnancy and pregnancy on HIV

    Potential for MTCT

    Risk

    Timing

    Prevention

    Use of antiretroviral (ARV) agents and other drugs

    during pregnancy, if available

  • 8/7/2019 Hrsa Hiv Pregncy

    10/30

    10

    Special Counseling Issues for HIV-Positive Women

    Who Are Pregnant or Considering Pregnancycontinued

    Newborn feeding options

    Disclosure issues concerns about stigma and violence

    Use of condoms

    Long-term health of mother and care for children

    Pregnancy termination option if legal and safe

  • 8/7/2019 Hrsa Hiv Pregncy

    11/30

    11

    Effect of Pregnancy on HIV

    CD4 count decreases in all pregnancies due to dilutional

    effect; CD4% remains stable in HIV-positive women

    HIV-RNA levels (viral load) remain stable during

    pregnancy in absence of treatment

    No significant differences in HIV progression or survival

    between pregnant and nonpregnant women with HIV

    infection

    Source: Alliegro 1997 Brocklehurst 1998 Burns 1998.

  • 8/7/2019 Hrsa Hiv Pregncy

    12/30

    12

    Effect of HIV on Pregnancy

    Pregnancy Outcome Relationship to HIV Infection

    Spontaneous abortion Limited data, but evidence of possible increased risk

    Stillbirth Evidence of increased risk in developing countries

    Perinatal mortality Evidence of increased risk in developing countries

    Infant mortality Evidence of increased risk in developing countries

    IUGR Evidence of possible increased risk

    Low birth weight (

  • 8/7/2019 Hrsa Hiv Pregncy

    13/30

    13

    Estimated Number of Children (< 15 years)

    Newly Infected with HIV during 2000

    WesternEurope

    < 500< 500North

    Africa& MiddleEast

    11,00011,000Sub-SaharanAfrica

    520,0520,0

    0000

    EasternEurope &

    Central Asia

    600600East Asia &Pacific

    2,6002,600South &South-EastAsia

    65,00065,000Australia &

    NewZealand

    < 100< 100

    NorthAmerica

    < 500< 500Caribbean4,2004,200

    LatinAmerica

    7,3007,300

    Total: 600,000Total: 600,000Source: UNAIDS December 2000.

  • 8/7/2019 Hrsa Hiv Pregncy

    14/30

    14

    Estimated Timing and Risk of MTCT of

    HIV (Absolute Rates)

    NoBreastfeeding

    Breastfeedingthrough 6Months

    Breastfeedingthrough 1824

    Months

    Intrauterine 5 to 10% 5 to 10% 5 to 10%

    Intrapartum 10 to 20% 10 to 20% 10 to 20%

    Postpartum

    Early (first 2 months) 5 to 10% 5 to 10%

    Late (after 2 months) 1 to 5% 5 to 10%

    Overall 15 to 30% 25 to 35% 30 to 45%

    Source: DeCock et al 2000.

  • 8/7/2019 Hrsa Hiv Pregncy

    15/30

    15

    Factors Affecting MTCT of HIV/AIDS

    Viral load (HIV-RNA level)

    Genital tract viral load

    CD4 cell count

    Clinical stage of HIV

    Unprotected sex with

    multiple partners

    Smoking cigarettes

    Substance abuse

    Vitamin A deficiency

    Photo: Nelson, Zambia 2000.

  • 8/7/2019 Hrsa Hiv Pregncy

    16/30

    16

    STIs and other co-infections

    ARV agents

    Preterm childbirth

    Placental disruption

    Invasive fetal monitoring

    Duration of membrane

    rupture

    Vaginal childbirth versus

    cesarean section

    Breastfeeding

    Factors Affecting MTCT of HIV/AIDScontinued

    Photo: Nelson, Zambia 2000.

  • 8/7/2019 Hrsa Hiv Pregncy

    17/30

    17

    MTCT Prevention in Low-Resource

    Settings

    Change behavioral factors

    Encourage consistent condom use during pregnancy and

    postpartum

    Discourage use of drugs, alcohol and cigarettes

    Identify and treat modifiable risk factors

    Screen and treat STIs and co-infections

    Provide vitamin A supplementation, if available (?)

    Recommend treatment for substance abuse

  • 8/7/2019 Hrsa Hiv Pregncy

    18/30

    18

    MTCT Prevention in Low-Resource

    Settings continued

    Reduce viral exposure

    Avoid:

    Artificial membrane rupture

    Transfusion (use only in life-threatening situations)

    Shorten duration of ruptured membranes

    Cleanse vaginal area with disinfectant (?)

    Reduce viral load before childbirth

    Administer ARV agents

    Treat STIs

  • 8/7/2019 Hrsa Hiv Pregncy

    19/30

    19

    MTCT Transmission with Short Course

    Oral ARV Regimens

    Site Regimen

    MTCTReduction

    No Breastfeeding

    Thailand ZDV: 36 weeks, labor 50%

    Breastfeeding

    Cote dIvoire ZDV: 36 weeks, labor 37%(3 months)

    ZDV: 36 weeks, labor,postpartum (mother)

    34%(18 months)

    Uganda, Tanzania,South Africa ZDV/3TC: 36 weeks, labor,postpartum (mother & newborn) 52%(6 weeks)

    ZDV/3TC: labor,postpartum (mother & newborn)

    38%(6 weeks)

    Uganda NVP (single dose): labor, postpartum(newborn)

    41%(18 months)

  • 8/7/2019 Hrsa Hiv Pregncy

    20/30

    20

    Recommendations for Antenatal Care

    Basic antenatal care

    Prevent and treat common opportunistic infections

    Recommend nutritional interventions

    Screen and treat STIs and other co-infections

    Monitor for signs and symptoms of progressive

    HIV/AIDS

    Counsel on safe sex practices

  • 8/7/2019 Hrsa Hiv Pregncy

    21/30

    21

    Recommendations for Antenatal Carecontinued

    Avoid invasive procedures

    Amniocentesis

    External cephalic version

    Consider administering ARV agents, if available

    Plan for future

    Newborn feeding

    Family planning

    Long-term care needs for mother, newborn and otherchildren

    Provide emotional support

  • 8/7/2019 Hrsa Hiv Pregncy

    22/30

    22

    Recommendations for Labor and

    Childbirth

    Avoid invasive procedures

    Artificial membrane rupture

    Fetal scalp electrode or sampling

    Forceps or vacuum extractor

    Episiotomy

    Administer ARV agents, if available

    Consider issues related to type of delivery cesarean

    section versus vaginal childbirth Wipe newborn quickly and thoroughly with a dry cloth to

    remove maternal blood and secretions

  • 8/7/2019 Hrsa Hiv Pregncy

    23/30

    23

    Recommendations for Labor and

    Childbirth continued

    Follow recommended infection prevention practices

    Wash hands thoroughly before and after each procedure

    and examination

    Wear hand and eye protection Handle needles and other sharp instruments safely

    Dispose placenta and other waste materials and supplies

    properly

    Process instruments, gloves and other items by

    decontamination, cleaning and either sterilization or high-

    level disinfection

  • 8/7/2019 Hrsa Hiv Pregncy

    24/30

    24

    MTCT and Cesarean Section

    Cesarean section before onset of labor and membrane

    rupture decreases risk of MTCT 5080%

    Additional benefit in women not using ARV agents or on

    ZDV alone No evidence of benefit after onset of labor or membrane

    rupture

  • 8/7/2019 Hrsa Hiv Pregncy

    25/30

    25

    MTCT and Cesarean Section continued

    Special concerns with cesarean section in limited-

    resource settings

    Increased maternal morbidity and possible mortality

    Availability of blood and blood safety Iatrogenic prematurity

    Antibiotic prophylaxis

    Anesthesia availability

    Limited human resources nursing care time

  • 8/7/2019 Hrsa Hiv Pregncy

    26/30

    26

    Postpartum Care

    Assess healing

    Review newborn feeding, growth and development

    Reinforce safer sexual practices

    Discuss contraception options

    Refer mother and newborn for ongoing care

  • 8/7/2019 Hrsa Hiv Pregncy

    27/30

    27

    Recommendations for Breastfeeding

    Avoid all breastfeeding when replacement feeding is

    acceptable, feasible, affordable, sustainable and safe

    Provide guidance and support to HIV-positive mothers who

    choose not to breastfeed to ensure adequate nutrition If breastfeeding chosen, encourage exclusive

    breastfeeding up to 6 months of infants life

    Teach proper attachment of newborn to nipples and

    frequent breast emptying

    Teach prevention and recognition and encourage prompt

    treatment of mastitis, breast abscess, cracked nipples and

    oral thrush or other oral lesions in newborns

  • 8/7/2019 Hrsa Hiv Pregncy

    28/30

    28

    Botswana Kenya Malawi Tanzania Zambia Zimbabwe

    0

    50

    100

    150

    200

    250Deaths per 1000 live births

    WithoutAIDS

    WithAIDS

    Estimated Impact of AIDS On Under-5 Child

    Mortality Rates Selected African Countries, 2010

    Source: UNAIDS June 2000.

  • 8/7/2019 Hrsa Hiv Pregncy

    29/30

    29

    WesternEurope

    9,0009,000North

    Africa& MiddleEast

    15,00015,000Sub-SaharanAfrica

    12.112.1millionmillion

    EasternEurope &

    Central Asia

    500500East Asia &Pacific

    5,6005,600South &

    South-EastAsia

    850,000850,000Australia

    & NewZealand

    < 500< 500

    NorthAmerica

    70,0070,00

    00Caribbean85,0085,0000Latin

    America

    110,0110,0

    0000

    Total: 13.2 millionTotal: 13.2 million* HIV-negative children who have lost their mother or both parents to AIDS before the age of 15 years

    Estimated Number of Children (< 15

    years) Orphaned by AIDS* by End of 1999

    Source: UNAIDS December 2000.

  • 8/7/2019 Hrsa Hiv Pregncy

    30/30

    30

    Summary

    Prevent HIV infection in women in their childbearing

    years

    Prevent unintended pregnancies in HIV-positive women

    Identify HIV infection in pregnant women

    To provide effective antenatal, labor and childbirth, and

    postpartum care can be provided

    To reduce risk of MTCT